BioPorto Announces Q3 2019 Report

    NEXT STORY
    Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
    PREV STORY
    Molecular Templates, Inc. Announces Proposed Public Equity Offering
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    GeoVax Announces Publication of HIV Vaccines Review

    Comprehensive Review Published in the Peer-Reviewed Journal, Clinical Pharmacology and Therapeutics ATLANTA, GA, Oct. 22, ...

    author_avatar
    NASDAQ Market News

    European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma

    author_avatar
    NASDAQ Market News

    DSS BioHealth Security, Inc. Announces the Addition of Mr. Daryl Thompson and Dr. Roscoe Moore to Advisory Team

    author_avatar
    NASDAQ Market News